All studies
Active not recruitingNAINTERVENTIONAL

The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study

This study is investigating a special heart valve called the Harmony Transcatheter Pulmonary Valve (TPV) System. It's designed for individuals born with certain heart problems affecting their pulmonary valve, such as Tetralogy of Fallot or issues with the right side of their heart. When this valve doesn't work correctly, it can lead to blood leaking backwards, which is called pulmonary regurgitation. The main goal of this research is to check how safe and effective the Harmony TPV system is over many years. Researchers are particularly interested in understanding its long-term performance after it has been put in without open-heart surgery, offering a less invasive way to help people with these conditions. This is a follow-up to earlier stages of the study, ensuring the valve continues to work well for those who have received it.

At a glance

Status
Active not recruiting
Phase
NA
Sponsor
Medtronic Heart Valves
Enrolment target
86
Start
01 Jan 2017
Estimated completion
01 Feb 2031

Results

Results from this study

Posted December 2021

Results have been published for this study.

Primary outcome
Freedom From Procedure- or Device-related Mortality at 30 Days.
The primary safety endpoint is point estimate of freedom from procedure or device-related mortality rate at 30 days post procedure.
Full results on the registry

What is this study about?

This study is all about a special kind of heart valve called the Harmony TPV system. It's for people who were born with certain heart conditions, like Tetralogy of Fallot, where parts of their heart haven't formed quite right. Sometimes, this can affect the 'pulmonary valve,' which controls blood flow from the heart to the lungs. If this valve doesn't close properly, blood can leak backwards into the heart, a problem called pulmonary regurgitation. This can make the heart work harder and lead to symptoms over time.

Traditionally, fixing valve problems often involved open-heart surgery. However, the Harmony TPV is designed to be put into place using a small tube (a catheter) that doctors guide into the heart without needing major surgery. This study is continuing to look at how well this new valve works and how safe it is over a long period. Many people have already had the Harmony TPV fitted, and this research is now following them up for longer to make sure the valve keeps working well for many years to come.

Essentially, the study aims to confirm that this innovative valve helps people live healthier lives with their heart conditions. By gathering more information over several years, doctors can better understand the long-term benefits of this less invasive way of treating these specific heart problems.

Key takeaways

  • This study evaluates the long-term safety and effectiveness of the Harmony TPV heart valve.
  • It's for people born with specific heart conditions affecting their pulmonary valve.
  • The Harmony TPV is designed to be a less invasive treatment option.
  • This phase focuses on following up with participants who already have the valve.
  • It aims to understand how the valve performs over many years.
  • You have the right to withdraw from the study at any time.

Who may be eligible?

This study is looking for people who have a significant leak in their pulmonary valve, meaning blood is flowing backward into their heart. Doctors will check this using special scans like an echo or an MRI. You would also need to be someone for whom doctors would normally consider surgery to repair or replace a heart valve or tube in the same area of the heart. Lastly, you must be willing to agree to participate in the study if you meet the other requirements.

However, some people would not be able to join. This includes individuals who have already had an operation to put in a special tube or a different man-made valve in a specific part of their heart (called the RV-PA conduit). Also, if the shape or structure of your heart in that area isn't suitable for the Harmony TPV device to be safely put in, you wouldn't be able to take part. For women, a positive pregnancy test would also mean you couldn't join. Finally, if doctors believe you have less than a year to live due to other serious health issues, you would not be eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Do I have a significant leak in my pulmonary heart valve?
  2. Am I being considered for heart valve surgery by my doctor?
  3. Have I previously had a specific type of heart repair called an RV-PA conduit?
  4. Is my heart's structure suitable for a TPV device?
  5. Am I willing to have regular check-ups as part of the study?
Answer every question to see your result.

What does participation involve?

This study is mainly about following up with people who have already had the Harmony TPV device fitted. If you are part of this study, you will have regular check-ups and tests, typically involving visits to the hospital, to see how the valve is working and how you are feeling. These visits will likely include heart scans like echocardiograms or MRI scans. The aim is to follow people for a long time, extending up to ten years for some participants, to understand the long-term effects of the valve. There are no new medications being given as part of this follow-up study, as it focuses on the already implanted valve. The exact number of visits will depend on how long you have been in the study, but each visit helps doctors gather important information about the Harmony TPV.

Potential risks and benefits

Taking part in this study could offer the benefit of continued close monitoring of your heart health, ensuring the Harmony TPV device is functioning correctly long-term. This ongoing care might provide reassurance. As with any medical procedure or device, there are potential, though rare, risks. These could include complications related to the original valve placement or issues that might arise over time with an implanted device, such as infection or device malfunction. Any medical investigation carries a small risk, but the study team will monitor you closely. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (12)

  • Ronald Regan UCLA Medical Center
    Verified postcode
    Los Angeles, United States
  • Stanford University Medical Center
    Verified postcode
    Palo Alto, United States
  • Yale University
    Verified postcode
    New Haven, United States
  • Mayo Clinic
    Verified postcode
    Rochester, United States
  • Nationwide Children's Hospital
    Verified postcode
    Columbus, United States
  • The Children's Hospital of Philadelphia
    Verified postcode
    Philadelphia, United States
  • Texas Children's Hospital
    Verified postcode
    Houston, United States
  • Primary Children's Hospital
    Verified postcode
    Salt Lake City, United States
  • Seattle Children's Hospital
    Verified postcode
    Seattle, United States
  • The Hospital for Sick Children (SickKids)
    Verified postcode
    Toronto, Canada
  • Toronto General Hospital
    Verified postcode
    Toronto, Canada
  • National Cerebral and Cardiovascular Center
    Verified postcode
    Suita, Japan

Common questions

What is the Harmony TPV system?

It's a special heart valve designed to fix problems with the pulmonary valve, often in people born with heart conditions. It's put in using a tube, not open-heart surgery.

Why is this study happening?

The study wants to check if the Harmony TPV valve is safe and works well for a long time after it's been put into people's hearts.

Who is this study for?

It's for people who have a significant leak in their pulmonary heart valve and would normally be considered for surgery to fix it.

Will I get a new valve if I join?

No, this specific part of the study is for people who have already had the Harmony TPV valve fitted in earlier stages of research. It's about long-term follow-up.

How long will I be followed in the study?

The study aims to follow participants for an extended period, potentially up to ten years, to understand the long-term performance of the valve.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.